Brickell Biotech, Inc. (BBI) Tops Q2 EPS by $1.43

Brickell Biotech, Inc. (NASDAQ: BBI) reported Q2 EPS of ($0.01), $1.43 better than the analyst estimate of ($1.44). Revenue for the quarter came in at $4.3 million versus the consensus estimate of $3.14 million.

For earnings history and earnings-related data on Brickell Biotech, Inc. (BBI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c